REGN
Regeneron Pharmaceuticals
NASDAQ · Biotechnology
$785.51
+18.88 (+2.46%)
Performance
1D
—
1W
+4.04%
1M
+2.28%
3M
+16.45%
6M
+39.88%
1Y
+13.78%
YTD
+1.19%
Open$769.63
Previous Close$766.63
Day High$786.99
Day Low$764.78
52W High$821.11
52W Low$476.49
Volume671.4K
Avg Volume871.4K
Market Cap83.03B
P/E Ratio18.43
EPS$41.56
SectorBiotechnology
Volume Analysis
0.77x average volume
Technical Indicators
SMA 50
$758.71
Above
SMA 200
$623.62
Above
RSI (14)
69.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
30 analysts
Price Target
-90.2% upside
Current
$785.51
$785.51
Target
$76.80
$76.80
$61.79
$76.80 avg
$111.17
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 13.96B | 13.22B | 58.28B |
| Net Income | 4.38B | 3.74B | 1.54B |
| Profit Margin | 31.4% | 29.8% | 2.7% |
| EBITDA | 4.21B | 3.79B | 2.09B |
| Free Cash Flow | — | — | 742.46M |
| Rev Growth | +5.6% | +5.6% | +14.8% |
| Debt/Equity | 0.09 | 0.09 | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |
| INSM | Insmed Inc | $149.86 | -0.77% | — | 31.96B |